Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease
S. Daum et al., Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease, GUT, 44(1), 1999, pp. 17-25
Background-Extracellular matrix (ECM) degradation may play a role in villus
atrophy in coeliac disease (CD).
Aims-To compare the cellular expression of mRNA transcripts for the two maj
or matrix degrading proteases, matrix metalloproteinase (MMP)-1 and MMP-3,
their inhibitor, tissue inhibitor of metalloproteinases (TIMP)-1, and proco
llagen I in the intestinal mucosa of patients with untreated and treated CD
and normal controls.
Patients/Methods-Duodenal biopsy specimens from ten untreated CD patients,
from six of these after a gluten free diet, and from ten control patients w
ere hybridised with S-35-labelled RNA probes. The number of positive cells
in the subepithelial region and lamina propria were counted microscopically
.
Results-The numbers of cells positive for MMMP-1 (p<0.005), MMP-3 (p<0.01),
and TIMP-1 (p<0.05) mRNA were higher in the subepithelial region of CD muc
osa than in that from controls. In the lamina propria, only cells positive
for MMP-1 mRNA were increased in CD patients compared with controls (p<0.01
). MMP-1 and MMP-3 mRNA expression returned to normal in CD patients after
treatment with a gluten free diet (p<0.05), while TIMP-1 mRNA expression re
mained elevated. The number of procollagen I mRNA expressing cells did not
change. Expression of MMP-1 and MMP-3 mRNA was mainly localised to subepith
elial fibroblasts and macrophages.
Conclusions-The decreased ratio of collagen I and TIMP-1 mRNA expressing ce
lls to MMP-1 and MMP-3 mRNA expressing cells in untreated CD suggests a shi
ft towards ECM degradation. ECM degradation by activated subepithelial fibr
oblasts and macrophages may be an important mechanism driving mucosal trans
formation in CD.